Fluconazole Coadministration Concurrent with Cyclophosphamide Conditioning May Reduce Regimen-Related Toxicity Postmyeloablative Hematopoietic Cell Transplantation
Open Access
- 1 July 2007
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13 (7) , 760-764
- https://doi.org/10.1016/j.bbmt.2007.03.005
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapyBritish Journal of Cancer, 2006
- Role of Hepatic Cytochrome P450s in the Pharmacokinetics and Toxicity of Cyclophosphamide: Studies with the Hepatic Cytochrome P450 Reductase Null MouseCancer Research, 2005
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 2005
- Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplantsBlood, 2004
- Cyclophosphamide metabolism is affected by azole antifungalsBlood, 2004
- Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantationBlood, 2003
- Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatinAnnals of Oncology, 2002
- The Effect of Fluconazole on Cyclophosphamide Metabolism in ChildrenDrug Metabolism and Disposition, 1999
- Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind StudyThe Journal of Infectious Diseases, 1995